TAM
Taurus Asset Management Portfolio holdings
AUM
$986M
This Quarter Return
-6.04%
1 Year Return
+5.04%
3 Year Return
+26.94%
5 Year Return
+134.98%
10 Year Return
+234.76%
AUM
$993M
AUM Growth
+$993M
(-6.4%)
Cap. Flow
+$4.64M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
45.49%
Holding
98
New
4
Increased
15
Reduced
49
Closed
9
Top Buys
| 1 |
Linde
LIN
|
$19.5M |
| 2 |
Envista
NVST
|
$13.9M |
| 3 |
Accenture
ACN
|
$11.9M |
| 4 |
Old Dominion Freight Line
ODFL
|
$9.62M |
| 5 |
Fortive
FTV
|
$5.79M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$24.1M |
| 2 |
Air Products & Chemicals
APD
|
$21M |
| 3 |
Ashland
ASH
|
$5.57M |
| 4 |
Johnson & Johnson
JNJ
|
$2.15M |
| 5 |
Thermo Fisher Scientific
TMO
|
$1.45M |
Sector Composition
| 1 | Technology | 26.04% |
| 2 | Healthcare | 19.21% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Financials | 12.37% |
| 5 | Consumer Staples | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Fortive
FTV
$16.2B
| $17.8M | 1.8% |
292,702
+94,980
| +48% | +$5.79M |
|
27
Ametek
AME
$42.7B
| $16.9M | 1.7% |
126,868
-1,500
| -1% | -$200K |
|
28
Mondelez International
MDLZ
$79.5B
| $14.7M | 1.48% |
234,506
-3,525
| -1% | -$221K |
|
29
Amphenol
APH
$133B
| $14.1M | 1.42% |
187,310
+4,585
| +3% | +$345K |
|
|
30
Envista
NVST
$3.52B
| $13.9M | 1.4% |
+285,400
| New | +$13.9M |
|
31
SPDR S&P 500 ETF Trust
SPY
$658B
| $13.8M | 1.39% |
30,536
+1,080
| +4% | +$488K |
|
|
32
Accenture
ACN
$162B
| $12.7M | 1.28% |
37,595
+35,310
| +1,545% | +$11.9M |
|
|
33
Ashland
ASH
$2.57B
| $11.2M | 1.13% |
113,726
-56,553
| -33% | -$5.57M |
|
|
34
Old Dominion Freight Line
ODFL
$31.7B
| $9.62M | 0.97% |
+32,216
| New | +$9.62M |
|
35
Enovis
ENOV
$1.77B
| $8.29M | 0.83% |
208,295
-4,115
| -2% | -$164K |
|
36
PepsiCo
PEP
$204B
| $8.28M | 0.83% |
49,491
-75
| -0.2% | -$12.6K |
|
37
EOG Resources
EOG
$68.2B
| $7.53M | 0.76% |
63,170
-1,800
| -3% | -$215K |
|
|
38
Johnson & Johnson
JNJ
$427B
| $7.47M | 0.75% |
42,156
-12,140
| -22% | -$2.15M |
|
39
Pfizer
PFE
$141B
| $3.43M | 0.35% |
66,251
-1,646
| -2% | -$85.2K |
|
40
Starbucks
SBUX
$100B
| $2.54M | 0.26% |
27,931
-948
| -3% | -$86.2K |
|
41
Exxon Mobil
XOM
$487B
| $2.49M | 0.25% |
30,116
-230
| -0.8% | -$19K |
|
42
Procter & Gamble
PG
$368B
| $2.39M | 0.24% |
15,609
-500
| -3% | -$76.4K |
|
43
Chevron
CVX
$324B
| $2.38M | 0.24% |
14,637
-232
| -2% | -$37.8K |
|
44
Abbott
ABT
$231B
| $2.18M | 0.22% |
18,424
-800
| -4% | -$94.7K |
|
45
NextEra Energy, Inc.
NEE
$148B
| $1.72M | 0.17% |
20,289
-175
| -0.9% | -$14.8K |
|
46
AbbVie
ABBV
$372B
| $1.68M | 0.17% |
10,389
-639
| -6% | -$104K |
|
47
3M
MMM
$82.8B
| $1.1M | 0.11% |
7,403
-515
| -7% | -$76.7K |
|
48
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.06M | 0.11% |
2
| – | – |
|
49
Altria Group
MO
$113B
| $1.01M | 0.1% |
19,360
-1,200
| -6% | -$62.7K |
|
|
50
Boston Scientific
BSX
$156B
| $1M | 0.1% |
22,628
-544,544
| -96% | -$24.1M |
|